NSTL国家科技图书文献中心

1. Current Perspectives of Immunotherapy for Hepatocellular Carcinoma NSTL国家科技图书文献中心

Liu, Xiaoyi | Lei, Xiaoyong ... - 《Combinatorial chemistry & high throughput screening》 - 2025,28(2) - 185～201 - 共17页

摘要：Hepatocellular carcinoma is the sixth most | recurrence. So, immunotherapy of hepatocellular carcinoma | immunotherapy for hepatocellular* carcinoma, including immune* | from major malignant tumors in China. Hepatocellular | carcinoma is a complex ecosystem containing non-tumor

关键词： Hepatocellular carcinoma | immunotherapy | clinical treatment | cancer | malignant tumor | HCC

2. lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy NSTL国家科技图书文献中心

Deng, Zhu-Jian | Liu, Hao-Tian ... - 《Clinical & translational oncology》 - 2025,27(4) - 1612～1622 - 共11页

摘要： non-coding RNA lncSNHG16 in hepatocellular carcinoma | ObjectiveTo investigate the expression of long | (HCC), associations between its expression and | patient survival, and its potential role in regulating | autophagy in the disease.MethodsExpression of lncSNHG16

关键词： Hepatocellular carcinoma | lncSNHG16 | Autophagy

3. A classification model for resectability in hepatocellular carcinoma patients NSTL国家科技图书文献中心

Nakamura, Ikuo | Yoh, Tomoaki ... - 《Hepatology research》 - 2025,55(1) - 94～105 - 共12页

摘要： for hepatocellular* carcinoma (HCC) have poor* | AimSome patients undergoing liver resection | outcomes. Therefore, we aimed to propose a new | resectability classification for patients with HCC. MethodsWe | classified patients into three categories: resectable (R

关键词： hepatectomy | hepatocellular carcinoma | resectability classification

4. Exploring extrahepatic metastasis of hepatocellular carcinoma based on methylation driver genes and establishing a prognostic model for hepatocellular carcinoma NSTL国家科技图书文献中心

Huang, ShiLing | Yang, Yang ... - 《Gene》 - 2025,933 - 148937～148937 - 共12页

摘要：Background: Hepatocellular* carcinoma (HCC* | ), the seventh most common cancer worldwide, is | characterized by a high mortality rate, advanced diagnosis | , and susceptibility to extrahepatic metastasis | . Numerous studies have shown that DNA methylation is a

关键词： Hepatocellular carcinoma | Extrahepatic metastasis | Methylation driver genes | Biomarkers | Prognosis model

5. Differences between hepatocellular carcinoma caused by alcohol and other aetiologies NSTL国家科技图书文献中心

Ganne-Carrie, Nathal... | Nahon, Pierre - 《Journal of Hepatology》 - 2025,82(5) - 909～917 - 共9页 - 被引量：3

摘要： leading cause of hepatocellular* carcinoma worldwide and* | these patients, the hepatocellular* carcinoma diagnosis* | mortality. However, when hepatocellular* carcinoma is* | -related hepatocellular* carcinoma. As a consequence, the* | hepatocellular carcinoma. Instead, prognosis is driven by liver

关键词： Alcohol-related liver disease | Metabolic Associated Steatotic Liver Disease with increased alcoholic intake (MetALD) | Cirrhosis | Hepatocellular carcinoma

6. ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma NSTL国家科技图书文献中心

Li, Jingtao | Zhong, Guocai ... - 《Cancer letters》 - 2025,611 - 217396～217396 - 共16页

摘要：Hepatocellular carcinoma (HCC) is resistant to | multiple conventional drugs including sorafenib, leading | to poor prognosis. Inducing cell death has been | inextricably pursued in therapeutics, although targeted | therapy and immunotherapy have made very limited

关键词： Hepatocellular carcinoma | Aspartate beta-hydroxylase | Metastasis | Sorafenib

7. EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma NSTL国家科技图书文献中心

Xingyi,Zhong | Zhiqin,Zhu ... - 《Apoptosis》 - 2025,30(1/2) - 349～363 - 共15页

摘要： ligand family, may influence hepatocellular carcinoma | Abstract EFNA4, a member of the Ephrin-A | cells through two distinct mechanisms: one reliant on | specific Eph receptor binding and the other independent | of receptor involvement. However, EFNA4's influence

关键词： Ephrin-A4 | EPHA2 | Hepatocellular carcinoma | Ferroptosis | Deubiquitination

8. How to Predict Recurrence After Resection of Hepatocellular Carcinoma NSTL国家科技图书文献中心

Petruch, Natalie | Bolm, Louisa ... - 《Anticancer Research》 - 2025,45(1) - 189～199 - 共11页

摘要： following resection of hepatocellular* carcinoma (HCC) are* | Background/Aim: Predictors of recurrence | not fully established. This study investigated | potential risk factors and prognostic scores for this | situation. Patients and Methods: In 297 patients

关键词： Hepatocellular carcinoma | surgcal resection | recurrence | prognostic score

9. Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma NSTL国家科技图书文献中心

Li, Han | Zhou, Chengyuan ... - 《Clinical & translational oncology》 - 2025,27(1) - 309～318 - 共10页

摘要：BackgroundIn AFP-negative hepatocellular | carcinoma patients, markers for predicting tumor | progression or prognosis are limited. Therefore, our | objective is to establish an optimal predicet model for | this subset of patients, utilizing interpretable

关键词： Machine learning | Hepatocellular carcinoma | AFP | Interpretable

10. Neoadjuvant therapy with triple therapy for centrally located hepatocellular carcinoma NSTL国家科技图书文献中心

Bo, Wentao | Zhang, Lixia ... - 《European Journal of Surgical Oncology》 - 2025,51(5) - 109588～109588 - 共7页

摘要：Background: Centrally located hepatocellular | carcinoma (HCC) is a subtype HCC with special location | adjoined hepatic portals. It is difficult to be radically | resected with sufficient surgical margin. We discussed | whether neoadjuvant therapy could increase surgical

摘要：Hepatocellular carcinoma is the sixth most | recurrence. So, immunotherapy of hepatocellular carcinoma | immunotherapy for hepatocellular* carcinoma, including immune* | from major malignant tumors in China. Hepatocellular | carcinoma is a complex ecosystem containing non-tumor

关键词： Hepatocellular carcinoma | immunotherapy | clinical treatment | cancer | malignant tumor | HCC

摘要： non-coding RNA lncSNHG16 in hepatocellular carcinoma | ObjectiveTo investigate the expression of long | (HCC), associations between its expression and | patient survival, and its potential role in regulating | autophagy in the disease.MethodsExpression of lncSNHG16

关键词： Hepatocellular carcinoma | lncSNHG16 | Autophagy

摘要： for hepatocellular* carcinoma (HCC) have poor* | AimSome patients undergoing liver resection | outcomes. Therefore, we aimed to propose a new | resectability classification for patients with HCC. MethodsWe | classified patients into three categories: resectable (R

关键词： hepatectomy | hepatocellular carcinoma | resectability classification

摘要：Background: Hepatocellular* carcinoma (HCC* | ), the seventh most common cancer worldwide, is | characterized by a high mortality rate, advanced diagnosis | , and susceptibility to extrahepatic metastasis | . Numerous studies have shown that DNA methylation is a

关键词： Hepatocellular carcinoma | Extrahepatic metastasis | Methylation driver genes | Biomarkers | Prognosis model

关键词： Alcohol-related liver disease | Metabolic Associated Steatotic Liver Disease with increased alcoholic intake (MetALD) | Cirrhosis | Hepatocellular carcinoma

摘要：Hepatocellular carcinoma (HCC) is resistant to | multiple conventional drugs including sorafenib, leading | to poor prognosis. Inducing cell death has been | inextricably pursued in therapeutics, although targeted | therapy and immunotherapy have made very limited

关键词： Hepatocellular carcinoma | Aspartate beta-hydroxylase | Metastasis | Sorafenib

摘要： ligand family, may influence hepatocellular carcinoma | Abstract EFNA4, a member of the Ephrin-A | cells through two distinct mechanisms: one reliant on | specific Eph receptor binding and the other independent | of receptor involvement. However, EFNA4's influence

关键词： Ephrin-A4 | EPHA2 | Hepatocellular carcinoma | Ferroptosis | Deubiquitination

摘要： following resection of hepatocellular* carcinoma (HCC) are* | Background/Aim: Predictors of recurrence | not fully established. This study investigated | potential risk factors and prognostic scores for this | situation. Patients and Methods: In 297 patients

关键词： Hepatocellular carcinoma | surgcal resection | recurrence | prognostic score

摘要：BackgroundIn AFP-negative hepatocellular | carcinoma patients, markers for predicting tumor | progression or prognosis are limited. Therefore, our | objective is to establish an optimal predicet model for | this subset of patients, utilizing interpretable

关键词： Machine learning | Hepatocellular carcinoma | AFP | Interpretable

摘要：Background: Centrally located hepatocellular | carcinoma (HCC) is a subtype HCC with special location | adjoined hepatic portals. It is difficult to be radically | resected with sufficient surgical margin. We discussed | whether neoadjuvant therapy could increase surgical

关键词： Hepatocellular carcinoma | Neoadjuvant treatment | Centrally located

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Hepatocellular carcinoma is the sixth most | recurrence. So, immunotherapy of hepatocellular carcinoma | immunotherapy for hepatocellular carcinoma, including immune | from major malignant tumors in China. Hepatocellular | carcinoma is a complex ecosystem containing non-tumor

关键词： Hepatocellular carcinoma | immunotherapy | clinical treatment | cancer | malignant tumor | HCC

摘要： non-coding RNA lncSNHG16 in hepatocellular carcinoma | ObjectiveTo investigate the expression of long | (HCC), associations between its expression and | patient survival, and its potential role in regulating | autophagy in the disease.MethodsExpression of lncSNHG16

关键词： Hepatocellular carcinoma | lncSNHG16 | Autophagy

摘要： for hepatocellular carcinoma (HCC) have poor | AimSome patients undergoing liver resection | outcomes. Therefore, we aimed to propose a new | resectability classification for patients with HCC. MethodsWe | classified patients into three categories: resectable (R

关键词： hepatectomy | hepatocellular carcinoma | resectability classification

摘要：Background: Hepatocellular carcinoma (HCC | ), the seventh most common cancer worldwide, is | characterized by a high mortality rate, advanced diagnosis | , and susceptibility to extrahepatic metastasis | . Numerous studies have shown that DNA methylation is a

关键词： Hepatocellular carcinoma | Extrahepatic metastasis | Methylation driver genes | Biomarkers | Prognosis model

关键词： Alcohol-related liver disease | Metabolic Associated Steatotic Liver Disease with increased alcoholic intake (MetALD) | Cirrhosis | Hepatocellular carcinoma

摘要：Hepatocellular carcinoma (HCC) is resistant to | multiple conventional drugs including sorafenib, leading | to poor prognosis. Inducing cell death has been | inextricably pursued in therapeutics, although targeted | therapy and immunotherapy have made very limited

关键词： Hepatocellular carcinoma | Aspartate beta-hydroxylase | Metastasis | Sorafenib

摘要： ligand family, may influence hepatocellular carcinoma | Abstract EFNA4, a member of the Ephrin-A | cells through two distinct mechanisms: one reliant on | specific Eph receptor binding and the other independent | of receptor involvement. However, EFNA4's influence

关键词： Ephrin-A4 | EPHA2 | Hepatocellular carcinoma | Ferroptosis | Deubiquitination

摘要： following resection of hepatocellular carcinoma (HCC) are | Background/Aim: Predictors of recurrence | not fully established. This study investigated | potential risk factors and prognostic scores for this | situation. Patients and Methods: In 297 patients

关键词： Hepatocellular carcinoma | surgcal resection | recurrence | prognostic score

摘要：BackgroundIn AFP-negative hepatocellular | carcinoma patients, markers for predicting tumor | progression or prognosis are limited. Therefore, our | objective is to establish an optimal predicet model for | this subset of patients, utilizing interpretable

关键词： Machine learning | Hepatocellular carcinoma | AFP | Interpretable

摘要：Background: Centrally located hepatocellular | carcinoma (HCC) is a subtype HCC with special location | adjoined hepatic portals. It is difficult to be radically | resected with sufficient surgical margin. We discussed | whether neoadjuvant therapy could increase surgical

关键词： Hepatocellular carcinoma | Neoadjuvant treatment | Centrally located

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Hepatocellular carcinoma is the sixth most | recurrence. So, immunotherapy of hepatocellular carcinoma | immunotherapy for hepatocellular* carcinoma, including immune* | from major malignant tumors in China. Hepatocellular | carcinoma is a complex ecosystem containing non-tumor

摘要： for hepatocellular* carcinoma (HCC) have poor* | AimSome patients undergoing liver resection | outcomes. Therefore, we aimed to propose a new | resectability classification for patients with HCC. MethodsWe | classified patients into three categories: resectable (R

摘要：Background: Hepatocellular* carcinoma (HCC* | ), the seventh most common cancer worldwide, is | characterized by a high mortality rate, advanced diagnosis | , and susceptibility to extrahepatic metastasis | . Numerous studies have shown that DNA methylation is a

摘要： following resection of hepatocellular* carcinoma (HCC) are* | Background/Aim: Predictors of recurrence | not fully established. This study investigated | potential risk factors and prognostic scores for this | situation. Patients and Methods: In 297 patients